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ABSTRACT
There are two major challenges in nucleic acid X-ray crystallography: crystallization and
phasing determination. With the introduction of selenium modification, the phasing problem can
be solved rationally, while the crystallization problem can be solved partially. By taking advantage
of the selenium modification, herein we report the synthesis of the Se-DNAs and the
thermostability and crystallization study of the DNA-small molecule complexes. 5-Se-thymidine
was successfully synthesized and incorporated into DNA oligonucleotides via solid-phase
synthesis in order to facilitate the crystallization and phasing. The UV-melting study reveals that
the selenium modification has caused no significate perturbation to the DNA stability. The small
molecules (DB2429 and DB2457) were co-crystalized with Se-DNAs and the Se-DNA crystals

were obtained, which are better than the native ones. In addition, our research suggested that the
DNA oligonucleotides with the 5’-overhang form better crystals than those with the 3’-overhang
or non-overhang. Our X-ray diffraction study is in progress.
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1
1.1

INTRODUCTION

Introduction of Central Dogma and Nucleic Acid Inhibition
Nucleic acids are macromolecules that store and transfer genetic information in

cells. They are ubiquitous in living systems. Nucleic acids, in the form of DNA and RNA,
play important roles in central dogma, controlling the synthesis of proteins from the origin13

. Inhibition of nucleic acid activities can allow disease intervention. Therefore, nucleic

acid molecules have become important drug targets4, 5. Unlike targeting proteins, inhibiting
nucleic acids offers great advantages: sequence-based targeting, understanding of the
underlying causes of diseases (such as gene expression disorders, viral infections and
cancer)5-7, and easy design of drugs with high specificity.
RNA Replication
DNA Replication

Reverse Transcription
DNA

RNA

Translation

Protein

Transcription
Figure 1.1 Schematic diagram of the central dogma. The solid arrows indicate the
direction in which genetic information is transmitted under normal conditions, and the
dashed arrows indicate the direction in which information is transmitted under
unconventional circumstances.

Recently, it has been found that functional nucleic acids (such as ribozyme and
DNazyme) can catalyze chemical and biochemical reactions like proteins3,

8-10

. The

functional nucleic acids, e.g., ribozymes, DNazymes, antisense nucleic acid molecules,
anti-gene sequences, nucleic acid aptamers, and small interfering RNAs3, 11, can also be
used as drugs to inhibit nucleic acids for treating diseases. Likewise, small molecules can
be designed to inhibit nucleic acids.
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Small molecules that recognize mixed base pairs nucleic acid sequences can be
used as transcription factor inhibitors by binding to a DNA promoter sequence rather than
by targeting the transcription factor part of the complex. The applications of gene specific
probes of this type are almost infinite.
To further understand the inhibition of functional nucleic acids and small molecules,
the study of the three-dimensional structure of nucleic acids, nucleic acid-small molecules
and nucleic acid-protein complexes by X-ray crystallography is important and has become
a very active research field. Our laboratory has found that selenium modification of nucleic
acids can facilitate crystallization and phasing for nucleic acid structure determination.
Therefore, by introducing selenium modification, we have investigated the Sederivatization and crystallization to accelerate the crystal structure determination of DNAsmall molecule complexes.3
1.2

Introduction of X-ray Crystallography
1.2.1

The function and application of X-ray crystallography

Proteins and nucleic acids (especially RNA) can fold into complicated threedimensional structures12. The structural information of nucleic acids is essential for gaining
insight into their biological functions. For example, after tRNA discovery, its role has been
a mystery for a long time13. Until 1974, the X-ray crystal structure of L-shaped tRNA was
successfully determined, and the mechanism of tRNA in protein biosynthesis was
gradually revealed13-15. Over the past two decades, due to advances in X-ray diffraction
crystallography, such as the development of crystallization science, the leap of synchrotron
performance, and the use of more advanced purification equipment, nucleic acid structure
detection has also been rapidly developed16. Consequently, more and more nucleic acid
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molecules with high-resolution structures have been discovered, especially non-coding
RNA molecules. At present, a large number of non-coding regulatory RNAs have been
discovered, such as ribozymes17, nucleic acid switches18, and so on. In addition, there are
many technological advances on potential nucleic acid therapeutics19, including antisense
oligonucleotide chains, small interfering RNAs, microRNAs20, and aptamers. These
studies demand advancements of structural and functional study of nucleic acids. Therefore,
new methods, especially new nucleic acid X-ray crystallographic techniques (such as
selenium modification), are urgently needed5.
1.2.2

Challenges and difficulties in nucleic acid X-ray crystallography

There are two bottlenecks in X-ray crystallography research itself: crystallization
and phase problem. These two bottlenecks much limit the discovery of new structures and
folding states of biological macromolecules (such as proteins and nucleic acids) and the
exploration of biological mechanisms3.
Compared to protein crystallography, nucleic acid X-ray crystallography has its
unique challenges and difficulties. The first is the crystallization of nucleic acids. A crystal
is a combination of a large number of molecules arranged in regular order, and the
molecules are grouped by non-covalent bonds21. The surface of a protein molecule has a
variety of structural and chemical groups that enable it to produce intermolecular
interactions that facilitate crystal growth. The surface of the nucleic acid molecule is
covered with dense, negatively charged phosphate groups, which makes it more difficult
to crystallize into agglomerates. The second difficulty is that the method of rationally
solving the phase problem of nucleic acid crystals has not been well developed so far. In
general, crystallographic phase problems can be solved in several different ways. The
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phase is determined by multi-wavelength anomalous diffraction (MAD) or singlewavelength anomalous diffraction (SAD)3. For example, the study of selenomethioninederived proteins is the most successful and reasonable method to solve the phase problem
of new protein crystal structure22. Currently, more than two-thirds of novel proteins are
structurally determined by this method23. If a similar structure can be obtained, the phase
problem of the protein structure can also be solved by molecular replacement24. However,
it is somewhat difficult to determine the structure of a nucleic acid molecule having a
highly repetitive unit by molecular replacement25. Heavy metal cation soaking and cocrystallization have also been successfully applied to protein crystallization, while nucleic
acid molecules with a phosphate backbone are often randomly hydrolyzed under these
conditions. Halogen-derived nucleic acid molecules can cause nucleic acid structure
perturbations and radiation instability. Therefore, due to the lack of convenient and stable
massive atom derivatives, the phase problem of nucleic acid is still a considerable
problem16. In addition to these two major challenges, there are other challenges in nucleic
acid crystallography. For example, it is difficult to obtain consistent and conformational
samples for crystallization and structural studies. In vitro enzymatic synthesis of DNA
sequences over 50 nt (e.g., larger non-coding RNA) produces significant heterogeneity.
Enzymatically synthesized nucleic acid sequences typically carry the 3'-end and/or 5'-end
heterogeneity that is undesired by high-resolution structural analysis. The multi-step
purification process is complicated and inefficient26. To increase the homogeneity of the
transcribed RNA and increase the transcription efficiency, the 2'-methylated DNA of the
last two nucleotides of the 5'-end was reported as a highly efficient template27. Another
difficulty in nucleic acid crystallography is the heterogeneity of the structure. Because a
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nucleic acid molecule (especially RNA) can be folded into many different threedimensional conformations21. In this case, it is necessary to find suitable refolding
conditions in order to obtain conformationally homogenized molecules for crystal
screening and structural studies. In order to solve all the above challenges and difficulties,
our group pioneered and developed a selenium nucleic acid (SeNA) strategy that rationally
solves the phase problem in nucleic acid crystallography5, 28-30.
1.3

Introduction of Selenium Nucleic Acid
1.3.1

The chemical and biochemical properties of selenium

Selenium (Se), like the oxygen and sulfur, is located in the sixth main group of the
periodic table. Therefore, their chemical properties are very similar, and there is a
possibility of mutual substitution. Although as early as 1817, selenium was discovered by
Jons Jakob Berzelius in plants enriched in selenium31. However, due to the toxicity of
selenium itself, there is seldom research work on it in the early years. Between the 1930s
and the 1950s, animal nutritionists and chemists had a great interest and curiosity about the
structure and function of selenium-containing compounds in selenium-containing plants32.
But unfortunately, these studies were not very successful and failed to identify any
selenium-containing compounds. This is most likely because these compounds are unstable
under separation conditions. Since the mid-1950s, the presence of selenium in proteins and
the critical role that selenium plays in a series of physiological processes have been
discovered, and research fields related to selenium have gradually attracted more and more
attention from scientists3, 33, 34.
Although it is toxic in the case of large intakes (it could cause selenium poisoning
if selenium intake exceeds 400 mg per day), selenium is widely recognized as a vital trace
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element35. Some plants are enriched in specific concentrations of selenium at individual
sites and are somewhat toxic to prevent them from being eaten by animals. Some plants,
such as mad grass, require selenium to grow, and their growth status can indicate the
presence and content of selenium in the soil36. It is also a constituent of the unnatural amino
acids selenocysteine and selenomethionine. In humans, selenium-containing compounds
can also act as cofactors for the reduction of antioxidant enzymes, such as glycoperoxidase
and some forms of thioredoxin reductase found in animals and some plants (these enzymes
are present in all organisms, but only some plants require selenium-containing
compounds)37-39. As a cofactor for three known thyroid deiodinases, selenium-containing
compounds also play an essential role in goiter. The further influence of seleniumcontaining compounds on human health, such as cancer, AIDS, tuberculosis, and diabetes,
is still controversial, and research work in this area is continuing40. In general, selenium in
the daily diet is mainly derived from nuts, grains, meat, fish, and eggs.
Like oxygen atoms (atomic radius 0.73 Å) and sulfur atoms (atomic radius 1.02 Å),
because of their similar chemical properties and electron distribution, in addition to
proteins, selenium atoms (atomic radius 1.16 Å) are also used in several transport RNAs.
Find. The predominant forms of selenium in natural transport RNA are 2-selenium-uridine
and 5-methylaminomethyl-2-selenour41. The selenium-modified uridine 2-position
selenium atom is introduced by the substitution of the 2-sulfur-uridine sulfur atom on the
transport RNA under the action of 2-selenium-uridine synthase. The selenium atom donor
is selenium phosphate42, 43. Selenium provides many unique biochemical and biological
functions and properties for RNA and protein. There are approximately 23 known
selenium-containing proteins in mammals44. In most selenium-containing enzymes,
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selenium is present in the form of a selenocysteine residue. Selenocysteine is considered
to be the 21st natural amino acid present in all organisms45. Also because of its large size
and chemical and electronic arrangement properties, selenium is found in the anti-codon
swing site of several bacterial transfer RNAs in the form of 5-methylamino-2-selenouridine,
including Lysine transfer RNA, glutamate transfer RNA, and glutamine transfer RNA46.
The function of the 2-position selenium atom of these modified nucleic acids is likely to
increase the speed and efficiency of the translation process. In vivo observations indicate
that selenium atoms can provide many useful and unique properties to natural RNA.
Because the mechanism of selenium modification of transfer RNA is still a mystery,
understanding the presence and function of selenium in proteins can be useful information
and inspiration for the functional study of selenium-modified RNA. Selenium atoms in
selenocysteine provide proteins with many unique properties different from oxygen and
sulfur47, 48. The most intuitive difference is that SeH with selenocysteine (pKa value of 5.2)
has a lower pKa value and a higher reduction potential than SH with a thiocysteine (pKa
value of 8.5)49, 50. Thus, at physiological pH, selenocysteine has stronger nucleophilicity
and better reducibility than native cysteine. These differences are the most fundamental
reason to explain the existence of selenocysteine in proteins, especially redox proteins,
because its presence can significantly increase the efficiency of redox reactions51,
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.

Selenium plays a significant role in the redox centers of several important
oxidoreductases53. Compared to a large amount of research work on naturally occurring
selenium-containing modified proteins, the study of selenium-modified naturally occurring
RNA appears to be very limited. Because selenium-modified RNA is difficult to obtain,
and the research is challenging. At the same time, the exciting research and development

22

of selenium-modified proteins has also stimulated the synthesis and research of naturally
occurring and non-natural selenium-modified RNAs.
1.3.2

Introduction of 5-Se-Tymidine modified nucleic acid

Because there are plenty of oxygen atoms can be modified in the nucleoside
molecule, the direct selenium modification method for nucleic acids can be varied
depending on the needs of the chemical system54. My research mainly focuses on the
crystallization and structural studies of DNA containing 5-position selenium-modified
thymidine.
The hydrogen bond is the interaction between the hydrogen bond acceptor and the
donor (X-H). In the hydrogen bond in the conventional sense, X refers to an electronpositive atom (oxygen atom, nitrogen atom, etc.). However, in recent studies, when X is
an electron-negative atom (such as a carbon atom), the hydrogen bond it generates is more
and more accepted and valued, such as hydrogen bonds in CH···O=C55-58. Interaction of
CH groups with hydrogen bond acceptors (electron donors), such as CH···O=C hydrogen
bonds in proteins56, CH···O=C hydrogen bonds in uracil crystals58, and host-guest systems
CH···Cl hydrogen bonds59 and other non-traditional interactions (such as CH···π
interactions in RNA)60 which plays a vital role in molecular recognition, catalysis, and
DNA double-strand stability in chemical and biological systems61,
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. Because the

negatively charged phosphate group is an excellent electron donor, and phosphorylation
and dephosphorylation are ubiquitous processes in the cell-regulatory mechanism63. Our
group studied the synthesis of a thymidine (5-Se-T) by introducing an atom probe (a
selenium atom) outside the 5-position of a heterocyclic base. The hydrogen bond
interaction between the 5-position methyl group of thymidine and its phosphate backbone

23

(hydrogen bond interaction of CH···O--PO3) exists54. The first synthesis of 5-position
methyl selenium modified thymidine was achieved via a method for introducing into 3',5'dibenzoyl-2'-deoxyuridine by electrophilic addition reaction through Mn(OAc)3 assisted
CH3SeSeCH3. The 5-position methyl selenide-modified thymidine dephosphoramidite
monomer was subsequently successfully synthesized and yielded a yield of more than 99%
during the coupling of DNA synthesis. Biophysical and structural studies of thymidinemodified DNA containing 5-methylselenolenium revealed that Se-modified DNA and
almost unmodified DNA are almost identical. At the same time, the structural analysis of
the crystallography of the thymidine modified by 5-methyl-selenium clearly indicates that
there is a hydrogen bond between the 5-methyl group and the 5'-position phosphate group
(CH3···PO4- interaction)54.
In the double-stranded DNA molecule64, the 5-position methyl group of the
thymidine is usually at a distance of 4 to 5 Å from the nearest oxygen atom on the 5'position phosphate group (O--PO3). In order to further extend the methyl group to bring it
closer to the phosphate group and at the same time increase the rotational flexibility of the
methyl group, an atomic bond is introduced between the methyl group of the thymidine
and the 5-position carbon atom65, 66. If the methyl and phosphate groups (O--PO3) are
capable of forming a real hydrogen bond, they can be observed in the crystal structure to
be close to each other, and the density of electron clouds in between them will be high. If
there is no such stable interaction between them, the steric hindrance forces the methyl
group to be more prone to rotation away from the phosphate group and to the direction of
the major groove. Since the position and spatial geometry of atoms and radicals have a
significant influence in this experimental study, it is chosen to insert a selenium atom
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between the 5-position methyl group and the 5-position carbon atom as an atom probe. And
a brand new methyl-hydrogen phosphate bond (C-H···O--PO3) is successfully discovered
54

.
1.3.3

Application of selenium nucleic acid in X-ray crystallography

As mentioned above, in crystal diffraction, selenium atoms can provide an
abnormal dispersion of electron centers, which can solve the phase problem well. The
selenomethionine (Se-Met) modification revolutionized the X-ray crystallography of
proteins. Especially after MAD analysis of selenomethionine-modified RNase H to
successfully obtain its crystal structure, this method is increasingly favored by researchers.
It is estimated that more than two-thirds of newly discovered protein structures are phased
by the Se-Met MAD method3, 5. Similarly, although somewhat time-consuming and labor
intensive, methods for determining the phase of nucleic acids by selenium-modified
proteins bound to nucleic acids have also been developed. Inspired by the revolutionary
advancement of protein X-ray crystallography by the substitution of sulfur atoms with
selenium atoms, our group pioneered the method of determining the phase and crystal
structure by replacing oxygen atoms at different positions in the nucleic acid with selenium
atoms.
This method of selenium modification has excellent potential for the study of the
structure and function of accounting. So far, studies have shown that the crystal samples
obtained by this method are more stable under X-ray irradiation than the conventional
bromine atom modification method67. At the same time, the selenium atom modification
method has more options than some limitations of the bromine modification method,
because many oxygen atoms in the nucleic acid molecule can be substituted. Also, based
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on the basic X-ray diffraction phase calculation, a modification of a selenium atom can
determine the phase of a 30 or more base DNA or RNA sequence68. Since the selenium
element and the oxygen element are located in the sixth main group of the periodic table,
it is possible to achieve a very significant change in the structure of the nucleic acid
molecule after replacing the oxygen atom with the selenium atom. In fact, this new
modification method has been used in many laboratories for X-ray diffraction
crystallography to analyze the molecular structure of DNA or RNA, such as ribozymes,
human DNA, and riboswitches69, 70. In order to further optimize this method, an enzymatic
process for preparing a selenium-modified nucleic acid molecule by a DNA synthase and
an RNA transcriptase has emerged71.
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2
2.1

EXPERIMENT

The Synthesis of 5-Se-T phosphorimidite Starting with 5’-DMTr-5-I-dU
Depending on the starting reactant, there are two different synthetic routes to

prepare 5-Se-thymidine-phosphoramidite, via the reaction with 5'-dimethoxytrityl-5iododeoxyuridine or 5-iododeoxyuridine as the initial reactant. Both routes have their
advantages and should be selected according to specific experimental needs54, 72.

Figure 2.1 Schematic diagram of the synthetic route of 5'-dimethoxytrityl-5methylselenodeoxyuridine phosphoramidite with 5'-dimethoxytrityl-5-iodo-deoxyuridine
as initial reactant.

The

synthesis

route

of

5'-dimethoxytrityl-5-methylselenodeoxyuridine

phosphoramidite with 5'-dimethoxytrityl-5-iodo-deoxyuridine (5'-DMTr-5-I-dU) as initial
reactant is shown in Figure 2.1. There are four steps in the route including tertbutyldimethylsilyl-(TBDMS-)

protection, the

detritylation, and the synthesis of phosphoramidite.

introduction

of methyl

selenium,
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2.1.1

Tert-butyldimethylsilyl-(TBDMS-) protection

The hydroxyl group at the 3'-position in the starting material is a good nucleophile.
To avoid its influence on the subsequent introduction of methyl selenium, it is necessary
to protect it with tert-butyldimethylsilyl group54, 72.
2.1.1.1 Experimental procedure

Figure 2.2 The reaction equation for the tert-butyldimethylsilyl protection reaction.
The reaction equation of 3’-DMTr-5-Iodo-dU (Compound 1) protection step is
shown in Figure 2.2. 1 g of Compound 1 was mixed with 408.6 mg of imidazole in a 25
mL round bottom flask. 452.1 mg TBDMS-Cl was placed in another 10 mL round bottom
flask. The flasks were dried over high vacuum for 30 min. The flasks were purged with
argon and an argon balloon was placed to maintain constant pressure and to ensure an argon
atmosphere during the reaction. TBDMS-Cl was dissolved in 7.5 mL of anhydrous DMF,
and a DMF solution of TBDMS-Cl was added dropwise to a round bottom flask containing
Compound 1 and imidazole. The reaction was stirred at room temperature overnight. The
progress of the reaction was monitored by TLC. The TLC eluent was a mixed solution of
ethyl acetate and hexane 1:2. After the reaction was completed, the reaction was quenched
by the addition of 0.7 mL of methanol. The reaction solution was diluted with ethyl acetate
and washed with water to remove DMF and other water-soluble impurities. The aqueous
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phase was extracted three times with ethyl acetate, the aqueous phase was discarded and
the organic phases were combined. The organic phase was washed three times with
saturated brine and the aqueous phase was discarded. The organic phase is dried over
anhydrous magnesium sulfate. After filtration and rotary evaporation, a crude product was
gained. Further purification using a silica gel column yields a product of higher purity. The
eluent of the silica gel column was a mixed solution of ethyl acetate and hexane 1:4. It
should be noted that dimethoxytrityl-(DMTr-)group is unstable under acidic conditions and
easily falls off into carbon cations. Since TBDMS-Cl is acidic, it cannot be mixed with
Compound 1. In addition, when purifying the silica gel column, a base such as N,Ndimethylethylamine should be used to neutralize the silica gel.
The yield for this step is about 90%.
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2.1.1.2 Proposed mechanism

Figure 2.3 Reaction mechanism of tert-butyldimethylsilyl protection reaction.

The reaction mechanism of this step is shown in Figure 2.3. First, the imidazole
replaces the chlorine atom of TBDMS-Cl to form a better leaving group, thereby activating
the silicon atom. Then, the hydroxyl group at the 3'-position of the sugar ring attacks the
silicon atom to undergo a substitution reaction. The role of imidazole in the reaction
process is the catalyst and proton acceptor.
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2.1.2

The introduction of methyl selenium

2.1.2.1 Experimental procedure

Figure 2.4 Reaction equation for introducing methyl selenium reaction.
The reaction equation of selenium introduction to 3’-DMTr-5’-TBDMS-5-Iodo-dU
(Compound 2) reaction is shown in Figure 2.4. 500 mg of Compound 2 was weighed into
a 25 mL round bottom flask. Another 23.4 mg of sodium hydride was weighed into another
25 mL round bottom flask. The flasks were dried over high vacuum for 30 min. The flasks
were purged with argon and an argon balloon was placed to maintain constant pressure and
to ensure an argon atmosphere during the reaction. Compound 2 was dissolved in 7.5 mL
of anhydrous tetrahydrofuran treated with sodium metal, and a solution of Compound 2 in
tetrahydrofuran was added dropwise to a round bottom flask containing sodium hydride.
The reaction was stirred at room temperature until no bubbles are produced. The reaction
flask was placed in a cooling bath of dry ice-acetone mixture (-78 °C). After the
temperature was constant, 1.04 mL of a 2.5 M n-butyllithium hexane solution was added
dropwise to the reaction flask using a syringe. The progress of the reaction was monitored
by TLC. The TLC eluent was a mixed solution of ethyl acetate and hexane 1:2. After all
the reactants were converted into intermediate products, 0.215 mL of dimethyl diselenide
liquid was added dropwise to the reaction flask with a syringe. The progress of the reaction
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was examined by TLC. After the reaction was completed, the reaction was quenched by
the addition of 0.7 mL of saturated brine. The reaction solution was diluted with ethyl
acetate, and washed with water to remove THF and other water-soluble impurities. The
aqueous phase was extracted three times with ethyl acetate, the aqueous phase was
discarded, and the organic phases were combined. The organic phase was washed three
times with saturated brine and the aqueous phase was discarded. The organic phase is dried
over anhydrous magnesium sulfate. After filtration and rotary evaporation, a crude product
was gained. Further purification using a silica gel column yields a product of higher purity.
The eluent of the silica gel column was a mixed solution of ethyl acetate and hexane 1:5.
When purifying on a silica gel column, a base should be used to neutralize the silica gel.
In addition, because dimethyl diselenide has a particularly pungent odor, the contact with
the dimethyl diselenide reaction vessel is oxidized by using a bleaching agent. Seleniumcontaining waste liquid should be collected in a specific container to avoid environmental
pollution.
The yield of this step is only 30%-40%.
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2.1.2.2 Proposed mechanism

Figure 2.5 Schematic diagram of the reaction mechanism for methyl selenium
introduction reaction.

The mechanism of this step is shown in Figure 2.5. First, sodium hydride removes
active protons in the molecule. Then, n-butyllithium converts iodine at the 5-position of
the base to lithium by a lithium-halogen exchange reaction. Currently, the carbon atom at
the 5-position becomes a suitable nucleophilic reagent, and the methyl selenization reaction
occurs in attacking dimethyl diselenide. Finally, during the quenching process by adding
saturated brine, the molecules acquire protons and restore electrical neutrality.
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2.1.3

Detritylation

2.1.3.1 Experimental procedure

Figure 2.6 The reaction equation of detritylation step.
The reaction equation of the deprotection of 3’-DMTr-5’-TBDMS-5-Se-Thymidine
(Compound 3) is shown in Figure. 2.6. 500 mg of Compound 3 was weighed into a 25 mL
round bottom flask. The flasks were dried over high vacuum for 30 min. The flasks were
purged with argon and an argon balloon was placed to maintain constant pressure and
ensure an argon atmosphere during the reaction. Compound 3 was dissolved in 13 mL of
anhydrous tetrahydrofuran. A round bottom flask containing the compound 3
tetrahydrofuran solution was placed in an ice water bath. After the temperature was
stabilized, 1.36 mL of a 1 M tetrabutylammonium fluoride solution in tetrahydrofuran was
added dropwise to a round bottom flask containing the compound 3 tetrahydrofuran
solution. The flask was removed from the ice water bath and stirred at room temperature
for two hours. The progress of the reaction was monitored by TLC. The TLC eluent was a
mixed solution of ethyl acetate and hexane 2:1. After completion of the reaction, the
reaction was quenched by the addition of 0.7 mL of saturated brine. The reaction solution
was diluted with ethyl acetate, and washed with water to remove THF and other watersoluble impurities. The aqueous phase was extracted three times with ethyl acetate, the
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aqueous phase was discarded and the organic phases were combined. The organic phase
was washed three times with saturated brine, and the aqueous phase was discarded. The
organic phase is dried over anhydrous magnesium sulfate. Filtration and rotary evaporation
gave a crude product. Further purification using a silica gel column yields a product of
higher purity. The eluent of the silica gel column was a 4% methanol-dichloromethane
mixed solution. When purifying on a silica gel column, a base should be used to neutralize
the silica gel.
The yield of this step is about 80%.
2.1.3.2 Proposed mechanism

Figure 2.7 Schematic diagram of the mechanism of detritylation reaction.

The mechanism of this step is shown in Figure 2.7. According to the nature of the
silicon-fluorine bond stronger than the silicon-oxygen bond, the fluoride ion attacks the
silicon atom to undergo a substitution reaction. The process of quenching the reaction by
adding saturated brine to obtain a proton of oxygen anion finally leads to an electrically
neutral hydroxyl group.
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2.1.4

The synthesis of phosphoramidite

2.1.4.1 Experimental procedure

Figure 2.8 Chemical reaction equation for phosphoramidite synthesis.
The reaction equation of the phosphoramidation of 3’-DMTr-5-Se-Thymidine
(Compound 4) is shown in Figure. 2.8. 365 mg of Compound 4 was weighed into a 25 mL
round bottom flask. The flasks were dried over high vacuum overnight. The flasks were
purged with argon and an argon balloon was placed to maintain constant pressure and to
ensure an argon atmosphere during the reaction. 318.7 μL of dimethylethylamine and
180.77 mg of i-Pr2NP(Cl)CH2CH2CN were simultaneously added to the round bottom flask
containing Compound 4 with a syringe. The reaction was stirred at room temperature for
half an hour. The progress of the reaction was monitored by TLC. The TLC eluent was a
mixed solution of ethyl acetate and hexane 2:1. After the reaction was completed, the
solvent was evaporated to dryness using a rotary evaporator. The phosphoramidite solid
crude product was dissolved in 4 mL of dichloromethane. 200 mL of hexane was placed in
a 500 mL beaker, and a solution of the phosphorous amide solid crude product in
dichloromethane was added dropwise with stirring. Stir for 10 minutes until the
precipitated precipitates all adhere to the beaker cup wall. The supernatant was decanted
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by decantation. The precipitated solid crude product was dissolved in dichloromethane and
dried. Further purification using a silica gel column immediately gave a product of higher
purity. The eluent of the silica gel column was a mixed solution of ethyl acetate and hexane
1:1.5. When purifying on a silica gel column, a base should be used to neutralize the silica
gel.
The yield of this step is about 60%.
2.1.4.2 Proposed mechanism

Figure 2.9 Schematic diagram of the mechanism of the phosphoramidite synthesis
reaction.

The mechanism of this step is shown in Figure 2.9. The chlorine atom is a preferred
leaving group, so the first step in the reaction is that the hydroxyl group attacks the
phosphorus atom to undergo a substitution reaction. The resulting acidic protons are
absorbed by dimethylethylamine, thereby causing the reaction to proceed in the forward
direction.
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2.2

Synthesis and Purification of the Selenium Nucleic Acids
2.2.1

Solid phase synthesis of the nucleic acid with selenium modification

Millions of oligonucleotides are synthesized and used in the laboratory every year
in the world. For most applications, only a very small amount of DNA is needed. Moreover,
the synthesis of oligonucleotides is mainly carried out at a scale below 40 nmol. This is
enough for most biological and biochemical experiments. But for biophysical studies such
as nuclear magnetic resonance and X-ray diffraction crystallography, more DNA (more
than 10 μmol) needs to be prepared. In extreme cases, it is often required to achieve
quantities of several kilograms for the preparation of drug molecules (e.g., antisense
oligonucleotides). Solid phase synthesis of oligonucleotides has emerged. And almost
exclusively fully automated solid phase synthesis can meet all of the above requirements73,
74

.
2.2.1.1 Advantages of solid phase synthesis
Solid phase synthesis is widely used in the synthesis of peptides, oligonucleotides,

oligosaccharides and various combinatorial chemistries. Solid-phase chemical synthesis
was invented by Bruce Merrifield in the 1960s, and he won the 1984 Nobel Prize in
Chemistry.
The starting reagent of the solid phase synthesis method is immobilized on a solid
support in the reaction column and the filter, and other reaction reagents and solvents can
freely pass through the reaction. Relative to solution synthesis, solid phase synthesis can
use a relatively large amount of solution phase reagent to promote the reaction to proceed
more quickly and thoroughly. Moreover, impurities and excess reagents are rinsed off so
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no additional purification process is required after each step is completed. At the same time,
the solid phase synthesis process can also be fully automated through a computer.
2.2.1.2 Solid supports
The solid support is an insoluble particle and usually has a particle size of 50-200
μm. During the synthesis, oligonucleotides are attached to these particles. There are many
different particles to choose from, but microporous glass (CPG) and polystyrene have
proven to be the most suitable.
2.2.1.2.1 Controlled-pore glass (CPG)
Controlled-pore glass is chemically stable, does not absorb solvent swelling, and
has deep pores that allow for oligonucleotide synthesis reactions. A glass support with a
pore size of 500 Å is suitable for mechanical synthesis of short-chain oligonucleotides.
However, when a 500 Å pore size vector is used to synthesize an oligonucleotide sequence
of more than 40 bases in length, the yield of the synthesis decreases sharply. This is because
the growing oligonucleotide strand blocks the micropores and prevents the reaction reagent
from diffusing into the support. Although larger pore size matrices are more fragile, it is
more appropriate to use controlled-pore glass with a pore size of up to 1000 Å when
synthesizing oligonucleotide sequences of up to 100 bases in length. Moreover, for the
synthesis of longer oligonucleotide sequences, it is even possible to use a vector with a
pore size of 2000 Å.
2.2.1.2.2 Polystyrene (PS)
Highly cross-linked polystyrene beads have good hydrophobicity and thus higher
oligonucleotide synthesis efficiency, especially at very low scales (eg 40 nmol). A solid
phase carrier for the synthesis of a conventional oligodeoxynucleotide is usually prepared
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by attaching 20-30 μmol of nucleoside per gram of the carrier. The efficiency of synthesis
of higher loading oligonucleotides is significantly reduced. This is because the steric
hindrance effect of the oligonucleotide strands adjacent to each other on the carrier
increases as the load increases. However, polystyrene carriers with a loading of up to 350
μmol / g are used in some applications, especially the synthesis of short-chain
oligonucleotides. This also makes it possible to synthesize a large number of
oligonucleotide sequences.
2.2.1.3 The phosphoramidite method
A variety of solution phase oligonucleotide synthesis methods have been developed
over the years. From the early studies of the hydrogen phosphite and phosphotriester
methods by Michelson and Todd in the 1950s75, 76, and the attempt of Khorana to the
phosphodiester method77, the re-study of the phosphotriester method and the development
of the phosphite triester method in the 1960s and 1970s78-83, all these methods have their
own drawbacks. The phosphoramidite method pioneered by Marvin Caruthers in the early
1980s combined with automated solid phase synthesis became the current universal
choice82.
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Figure 2.10 Schematic diagram of the process of DNA phosphoramidite solid phase
synthesis.

The phosphoramidite synthesis process is in the direction of synthesis from the 3'end to the 5'-end (opposite to the direction of DNA biosynthesis in the DNA replication
process). After each synthesis cycle is completed, one nucleotide is attached. The
phosphoramidite DNA synthesis involves a series of steps, as shown in Figure 2.16. In
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general, DNA phosphoramidite solid phase synthesis can be divided into four steps:
activation and coupling, capping, oxidation, and DMTr protection. After completing the
four steps, one cycle is completed and the synthetic oligonucleotide strand is increased by
one base. This is repeated until the final completion of the desired oligonucleotide sequence
for synthesis.
2.2.1.3.1 Detritylation of the support-bound 3’-nucleoside

Figure 2.11 Schematic diagram of the reaction mechanism of DMTr protection
under acid catalysis.

At the very beginning of the synthesis of the oligonucleotide strand, a nucleoside
protected by a protecting group has been attached to the vector. A DNA synthesis column
containing one of the four nucleosides A, C, G, and T is selected based on the nucleoside
of the 3'-end of the desired DNA molecule. The nucleoside attached to the carrier is
protected by a DMTr group at the 5'-position to prevent the corresponding polymerization
from occurring during the preparation of the carrier. Prior to synthesis, the DMTr
protecting group must be removed to ensure that the synthesis of the oligonucleotide is
possible. The mechanism of DMTr protection is shown in Figure 2.17. DMTr easily forms
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stable carbon cations under acidic conditions. The DMTr carbon cation is orange in
solution.
2.2.1.3.2 Activation and coupling (first step)

Figure 2.12 Schematic diagram of the reaction mechanism of the phosphoramidite
activation and coupling step.

After deprotection by DMTr, the nucleoside attached to the carrier is ready to react
with the next base. The reaction form of the base is a nucleoside phosphoramidite monomer.
A large excess of a mixed solution of acetonitrile (an excellent solvent in a nucleic acid
synthesis reaction) corresponding to a nucleoside phosphoramidite monomer and an
activator (tetrazole or a derivative thereof) is injected into a DNA synthesis column to
participate in the reaction. The diisopropylamino group on the nucleoside phosphoramidite
monomer is protonated by the activator to a good leaving group. The phosphorus atom
adjacent to it quickly attacks and undergoes a substitution reaction than the hydroxyl group
on the nucleoside attached to the carrier. A new phosphorus-oxygen bond is formed,
resulting in a phosphite triester attached to the support, as shown in Figure 2.18. The
nucleoside phosphoramidite monomer is quite stable in an inert gas environment. It can be
stored in large quantities, shipped to all parts of the world and can be used for several
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months in dry conditions. Only when the nucleoside phosphoramidite is protonated will it
become active.
2.2.1.3.3 Capping (second step)
Although the efficiency of the coupling reaction is quite high (up to 99.5%), there
is no guarantee that all of the nucleosides on the support will react with the
phosphoramidite monomer. This means that a small amount of nucleoside remains on the
carrier containing a 5'-terminal hydroxyl group which is not involved in the reaction. If left
untreated, it is possible for these 5'-terminal hydroxyl groups to react with the injected new
phosphoramidite monomer in the next coupling reaction. This results in the deletion of one
base by the synthetic oligonucleotide strand, which corresponds to a deletion mutation in
the target oligonucleotide strand. If these deletion mutations are left unchecked, they will
accumulate as the number of cycles is accumulated, making the final product a complex
mixture of multiple oligonucleotide strands. Most of them are erroneous genetic
information and are very difficult to purify. This will ruin subsequent biochemical
experiments.

Figure 2.13 Schematic representation of the reaction mechanism of the
phosphoramidite activation and coupling steps. The correct oligonucleotide sequence (top)
and the oligonucleotide sequence lacking one base (below) are deleted due to deletion of
the sixth thymine.

The "capping" step is introduced after the end of the coupling reaction to protect
the unreacted 5'-terminal hydroxyl group to avoid deletion mutations. Two capping
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solutions were used in the synthesizer: acetic anhydride and N-methylimidazole (NMI).
The two reagents (dissolved in tetrahydrofuran to which a small amount of pyridine was
added) were first mixed in a DNA synthesizer and then injected into a synthesis column.
The mixed solution of the electrophile rapidly acetylates the alcohol. The presence of
pyridine ensures that the reaction is carried out under basic conditions to avoid the reaction
of acetic anhydride with N-methylimidazole to produce an acidic material which could
remove the trityl group. The formylation at the 5'-end ensures a smooth follow-up reaction.
The mechanism of the acetylation reaction is shown in Figure 2.20.

Figure 2.14 Schematic diagram of the reaction mechanism of the acetylation
capping step during the synthesis of oligonucleotide sequences by the phosphoramidite
method.

2.2.1.3.4 Oxidation (third step)
The phosphite triester formed in the coupling reaction is unstable under acidic
conditions and must be converted to a more stable pentavalent phosphorus form prior to
the next step of trichloroacetic acid (TCA) deprotection with DMTr. This is achieved by
oxidation of iodine in the presence of water and pyridine. The reaction product
phosphotriester is an effective DNA backbone protected by 2-propionitrile. The
propionitrile group avoids unnecessary reactions that may occur on the phosphate group in
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subsequent synthesis cycles. The mechanism of the oxidation reaction is shown in Figure
2.21.

Figure 2.15 Schematic diagram of the reaction mechanism of the phosphite triester
oxidation step during the synthesis of the oligonucleotide sequence by the phosphoramidite
method.

In some DNA synthesizers, there is a capping step after the iodine oxidation
reaction. Its purpose is to dry the carrier. Because the moisture contained in the residual
oxidizing solution affects the subsequent coupling reaction. Excess water will react with
the acetylating reagent acetic anhydride to form acetic acid and be washed away by a
tetrahydrofuran-pyridine mixed solution.
2.2.1.3.5 Detritylation (fourth step)
After coupling, capping, and oxidation, the 5'-end DMTr protecting group of the
oligonucleotide strand attached to the carrier needs to be removed to obtain a free hydroxyl
group, so that the new phosphoramidite monomer can be neutralized in the next cycle. An
even reaction occurs. The de-DMTr-protected reaction under trichloroacetic acid in
dichloromethane was very rapid and quantitative. The detached DMTr carbon cation is
orange and can absorb visible light with a wavelength of 495 nm. The intensity of this
absorption is used to test the efficiency of the coupling reaction. Most commercial DNA
synthesizers support the ability to monitor the efficiency of synthesis in real time by
detecting and reporting the yield of each cycle of DMTr.
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The cycle is repeated, adding one base per cycle to finally synthesize the desired
oligonucleotide sequence.
2.2.1.4 Synthesis of oligonucleotide sequence containing 5-seleno-modified
thymidine using a DNA synthesizer
Our laboratory used a 3400 DNA synthesizer from Applied Biosystems. 25.6 mg
(1 μmol) of dG-CPG powder was weighed in four DNA synthesis columns, respectively.
The four base injection vials of the DNA synthesizer were loaded with enough four
phosphoramidite acetonitrile solutions. A sufficient 0.15 mol/L 5-position seleniummodified thymidine phosphoramidite acetonitrile solution was placed in the No. 5 solution
bottle. Set the synthesis procedure, the sequence of the synthesis column No. 1 is5'd(CCAAAGTTGC)-3'; the sequence of the synthesis column No. 2 is 5'd(GCAACTTTGG)-3'; the sequence of the synthesis column No. 3 is 5’d(CCAAAGT5TGC)-3’;

The

sequence

of

the

synthesis

column

is

5'-5’-

d(GCAACTT5TGG)-3’. To facilitate subsequent purification procedures, DMTr
protection was set up without taking off the last nucleoside. After the DNA was synthesized,
it was blown dry, transferred to a 1.5 mL centrifuge tube, and stored in a -80 ̊C refrigerator.
2.2.2

Deprotection and purification of the nucleic acid with selenium modified

DNA that has just been synthesized from a DNA synthesizer is clearly not directly
available for subsequent biochemical experiments. First, the synthetic oligonucleotide
strand is also attached to the vector and a separate treatment from the vector is required. In
addition, many nucleoside bases are protected by various groups and require deprotection.
Furthermore, some short-chain oligonucleotide strands are inevitably produced during
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DNA synthesis. Although they are capped, they still need to be removed to avoid
unnecessary trouble for subsequent experiments.
2.2.2.1 Principle of nucleic acid deprotection and purification
2.2.2.1.1 Isolation of the oligonucleotide strand from the vector
After the completion of the synthesis, the obtained 3'-end of the target
oligodeoxynucleotide chain is also linked to a complex on a solid phase carrier. This
complex must be stable during the synthesis of the solid phase oligonucleotide sequence,
but at the end of the synthesis it is necessary to be able to separate under certain conditions.
This complex is usually linked by succinyl. This connection structure can be separated by
reacting at room temperature for 1 h under concentrated ammonia conditions.
In some DNA synthesizers, the separation reaction can be automated. After the
reaction, the ammonia solution containing the oligonucleotide chain was transferred to a
glass bottle. The separation reaction can also be accomplished by manual manipulation.
2.2.2.1.2 Deprotection of oligonucleotide strands
The oligonucleotide strand dissolved in aqueous ammonia requires heat to remove
the heterocyclic base and the protecting group on the phosphate. Water and some volatile
components are then removed by lyophilization. The next step is to purify the
oligonucleotide strand.
2.2.2.1.3 Deprotection of heterocyclic bases
The primary amino group outside the ring of the heterocyclic base (A, C and G) is
a nucleophile and therefore must be protected prior to the DNA synthesis reaction. The
concentrated ammonia water used in the final deprotection treatment was reacted at 55 °C
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for 5 hours to effectively remove these protecting groups. The most commonly used
protection groups for these heterocyclic bases are shown in Figure 2.25.

Figure 2.16 Schematic diagram of the protective group structure of adenosine,
cytidine and guanosine commonly used in the synthesis of oligonucleotide sequences by
phosphoramidite solid phase synthesis.

The benzoyl protection on A and C is easily removed under aqueous ammonia
conditions. However, the isopropyl formyl protection on G is more stable, so the final step
of the deprotection reaction of the oligonucleotide chain is the reaction in which the
isopropyl formyl group is removed on G. In the case of synthesizing a chemically modified
oligonucleotide sequence, heating in aqueous ammonia may result in decomposition of the
compound. Thus, in this case, a more unstable guanosine protecting group is required. The
most popular active group protected guanosine is dimethylformamide guanosine (DMF
dG). This guanosine makes it possible to deprotect the oligonucleotide chain under
relatively mild conditions (reaction at 55 ºC in concentrated aqueous ammonia for 1 hour).
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2.2.2.1.4 Deprotection of the phosphate backbone
The phosphate group is always protected by the 2-propionitrile group during the
synthesis, so deprotection is also required after the reaction is completed. The propionitrile
group can be quickly removed under concentrated aqueous ammonia conditions. Since the
cyano group has a strong electron withdrawing property, the hydrogen atom on its adjacent
carbon atom thus exhibits a stronger acidity. The reaction was carried out in accordance
with the β-elimination mechanism.

Figure 2.17 A schematic diagram of the reaction mechanism for removing the
propionitrile group protection on the phosphate triester after synthesizing the
oligonucleotide sequence by the phosphoramidite method.

2.2.2.2 Nucleic acid deprotection and purification steps
To the synthesized DMTr-protected DNA-CPG carrier complex, 1 mL of
concentrated aqueous ammonia was added, and the reaction was heated at 55 °C overnight.
Transfer the supernatant to a 1.5 mL centrifuge tube A. The pellet was washed three
times with 1 mL of 100 mg/mL sodium chloride solution, and the supernatant was
transferred to a 1.5 Ml centrifuge tube B. The solutions of the centrifuge tubes A and B
were repeatedly mixed so that the salt concentration in the final two centrifuge tubes was
adjusted to 50 mg/mL.
Take 0.1 mL of the sample solution and centrifuge to remove the solid support.
Samples were analyzed using analytical HPLC. If the sample is relatively pure (the peak
area ratio of the target DNA is >80%), and the subsequent experiment does not require
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strict DNA purity, the DNA desalting column can be directly used for desalination
treatment. Otherwise, the sample needs to be purified using preparative HPLC.
The vacuum centrifuge was used for 1 h to remove most of the ammonia and some
volatile impurities from the solution. Separation tests were first performed in preparative
HPLC using a sample solution of about 5%. If the peak condition is normal, all samples
are separated using preparative HPLC. The purified DNA solution needs to be purified by
analytical HPLC. If the purity can meet the requirements of subsequent biochemical
experiments, it should be prepared for DMTr protection after lyophilization. If the purity
cannot meet the requirements of subsequent biochemical experiments, it needs to be re-run.
purification. The DMTr protection was performed by dissolving the sample in 0.5 mL of
ultrapure water and adjusting the pH to 4.5 using a 10% (v/v) aqueous solution of acetic
acid. Heating at 40 °C for 1 h. Samples were analyzed using analytical HPLC to ensure
that the DMTr protecting groups of all DNA molecules were removed. If multiple peaks
occur, purification by preparative HPLC is required once. Freeze to remove moisture and
volatile impurities. The sample was dissolved in 1 mL of ultrapure water to prepare for salt
removal.
For the desalination treatment, the desalting column was treated with 1 mL of
acetonitrile and 1 mL of 2 mol/L TEA·Ac aqueous solution. The sample is injected into a
desalting column. The desalting column was then rinsed three times with ultrapure water,
1 mL each time. Finally, the DNA was eluted from the desalting column using 1 mL of 30%
aqueous acetonitrile.
Freeze the sample. The DNA sample concentration was adjusted to 1 mmol/L using
an ultraviolet-visible absorber.
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2.3

Crystallization Procedure
2.3.1

Introduction for Hanging Drop Vapor Diffusion Crystallization

Figure 2.18 Hanging drop vapor diffusion crystallization

Hanging drop vapor diffusion technology is a useful method for macromolecular
crystallization. The principle of vapor diffusion is simple. The droplets consisting of a
mixture of sample and reagent are equilibrated with the liquid reagent container vapor.
Typically, the droplets contain a lower concentration of reagent than the reservoir. In order
to reach equilibrium, the water vapor leaves the water droplets and eventually reaches the
reservoir. As the water leaves the water droplets, the relative supersaturation of the sample
increases. As the water leaves the reservoir, the concentration of both the sample and the
reagent increases. Equilibrium is reached when the concentration of the reagent in the
droplet is approximately the same as the concentration of the reagent in the reservoir.84
There are pretty advantages for hanging drop vapor diffusion method. First, it can
be cost effective. We only need 1 μL of sample for each screening try. Second, the sample
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and reagents are in contact with a siliconized glass surface. The hydroxy groups in the glass
may accelerate the crystallization process. Third, when we want to access the crystal, it can
be straightforward. We only need to uncover the slide and mount the crystal. Last but not
least, we can perform multiple drops (experiments) with a single reservoir. The glass is
large enough to contain several sample drops simultaneously. It would cost even less, and
the comparison could be very convenient.
2.3.2

Sample Preparation

Macromolecular samples should be homogeneous, as pure as possible (> 95%) and
free of amorphous and particulate materials. The amorphous material is removed by
centrifugation or microfiltration before use. If necessary, we can use HPLC to purify the
sample.
The recommended sample concentration is 5 to 25 mg/mL in deionized water.
Initially, the sample should be free of any unnecessary additives to observe the effects of
the Crystal Screen variable. Ideally, the initial screening should be performed with a sample
that has been dialyzed against water, although the ligand, ion, reducing agent or other
additive required for the sample may be soluble, stable or active.84
2.3.3

Crystallization

Firstly, using a clean pipet tip, pipet 1.0 milliliter of crystallization reagent into
reservoir A1 of the Hampton Research VDX Plate. The recommended reservoir volume is
0.5 to 1.0 milliliters.
Then, clear a Siliconized 22 mm Circle or Square Cover Slide by wiping the cover
slide with lens paper and blowing the cover slide with clean, dry compressed air. Pipet 2
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microliter of the sample into the center of a Siliconized 22 mm Circle or Square Cover
Slide. The recommended total drop volume is 2 to 20 microliters.
Next, pipet 2 microliters of reagent from reservoir A1 into the drop on the cover
slide containing the sample.
Holding the cover slide with tweezers, the Pen-Vac, or on the edge between our
thumb and forefinger, carefully and without delay invert the cover slide, so the drop is
hanging from the cover slide.
Finally, position the cover slide onto the bead of grease on reservoir A1. Gently
press the slide down onto the grease and twist the slide 45ºto ensure a complete seal.
Repeat for reservoirs 2 (A2) through 24 (D6).73
2.4

Crystal and Structure Study of DND-small Molecule Complex
Designing and preparing novel compounds that recognize specific mixed base

sequences in nucleic acid sequences can make DNA a cellular receptor for therapeutic and
biotechnological applications as well as gene-specific probes. For example, if a small
molecule capable of binding to a DNA promoter is developed, regulation of the RNA
transcription process can be achieved. According to the central rule, the synthesis of
proteins is regulated accordingly. Using this idea can cure some diseases. The potential of
gene-specific probes in this area is limitless. The small molecules DB2429 and DB2457
can specifically recognize the presence of A·T base pairs and G·C base pairs in the DNA
minor groove. The 5-position selenium atom is located in the major groove, and the
structure of the DNA-small molecule complex can be obtained by X-ray diffraction
crystallographic analysis to determine whether the small molecule will also interact with
the DNA major groove position and how it acts.
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Figure 2.19 Schematic diagram of the molecular structure of two small molecules
DB2429 and DB2457.

In this experiment, four DNA sequences were synthesized, in which two natural
DNA sequences were: W1 5'-d(CCAAAGTTGC)-3' and W2 5'-d(GCAACTTTGG)-3'; the
selenium-modified DNA sequences were also two: W3 5 '-d(CCAAAGT5- SeTGC)-3' and
W4 5'-d(GCAACTT5- SeT GG)-3'. W1 and W3 are the same sequences. W2 and W4 are the
same, as well. W1 and W2 are complementary. These four DNA sequences can be
constructed into four double-stranded DNA molecules of W1-W2, W1-W4, W2-W3, and
W3-W4. W1-W2 is natural DNA. W1-W4 and W2-W3 contain a single selenium-modified
thymidine. W3-W4 contains two selenium-modifications.
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3
3.1

RESULTS

The Synthesis of 5-Se-T phosphorimidite Starting with 5-I-dU

Figure 3.1 Schematic diagram of the synthetic route for the synthesis of 5'dimethoxytrityl-5-methylseleno-deoxyuridinephosphoramidite using 5-iodo-deoxyuridine
as the starting reactant.

The

synthetic

route

of

synthesizing

5'-dimethoxytrityl-5-methylseleno-

deoxyuridine phosphoramidite with deoxyuridine (dU) as the initial reactant is shown in
Figure 3.1. There are 5 steps totally to synthesis phosphoramidite, including tertbutyldimethylsilyl (TBDMS-) protection, introduction of methyl selenium, detbutyldimethylsilyl protection and dimethoxytrityl (DMTr-) protection. An advantage of
this method compared to the former route is that in the step of introducing methyl selenium,
the group at the 5'-position changes from dimethoxytrityl group to tert-butyldimethylsilyl
group. The steric hindrance is significantly smaller, which increases the efficiency of
methyl selenization.
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3.1.1

Tert-butyldimethylsilyl (TBDMS-) protection

3.1.1.1 Experimental procedure

Figure 3.2 The reaction equation for the tert-butyldimethylsilyl protection reaction.

The reaction equation of the protection of 5-Iodo-dU (Compound 6) is shown in
Figure 3.2. 1 g of compound 6 was mixed with 3.08 g of imidazole in a 100 mL round
bottom flask. 3.4 g of TBDMS-Cl was placed in another 10 mL round bottom flask. The
flasks were dried over high vacuum for 30 min. The flasks were purged with argon and an
argon balloon was placed to maintain a constant pressure and to ensure an argon
atmosphere during the reaction. TBDMS-Cl was dissolved in 26 mL of anhydrous DMF,
and a DMF solution of TBDMS-Cl was added dropwise to a round bottom flask containing
compound 6 and imidazole. The reaction was stirred at room temperature overnight. The
progress of the reaction was monitored by TLC. The TLC developing solvent was a mixed
solution of ethyl acetate and hexane 1:2. After the reaction was completed, the reaction
was quenched by the addition of 0.7 mL of methanol. The reaction solution was diluted
with ethyl acetate and washed with water to remove DMF and other water-soluble
impurities. The aqueous phase was extracted three times with ethyl acetate, the aqueous
phase was discarded, and the organic phases were combined. The organic phase was
washed three times with saturated brine and the aqueous phase was discarded. The organic
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phase is dried over anhydrous magnesium sulfate. After filtration and rotary evaporation,
a crude product was gained. Further purification using a silica gel column yields a product
of higher purity. The eluent of the silica gel column was a mixed solution of ethyl acetate
and hexane 1:5.
The yield of this step is about 90%.
3.1.2

The introduction of methyl selenium

3.1.2.1 Experimental procedure

Figure 3.3 The reaction equation for introducing a methyl selenium reaction.
The reaction equation of the selenium introduction to 3’,5’-diTBDMS-5-Iodo-dU
(Compound 7) is shown in Figure 3.3. 900 mg of Compound 7 was weighed into a 100 mL
round bottom flask. Another 59 mg of sodium hydride was weighed into another 50 mL
round bottom flask. The flasks were dried over high vacuum for 30 min. The flasks were
purged with argon and an argon balloon was placed in the reaction flask to maintain a
constant pressure and to ensure an argon atmosphere during the reaction. The compound 7
was dissolved in 20 mL of anhydrous tetrahydrofuran treated with sodium metal, and a
solution of the compound 7 in tetrahydrofuran was added dropwise to a round bottom flask
containing sodium hydride. The reaction was stirred at room temperature until no bubbles
are produced. The reaction flask was placed in a cooling bath of dry ice-acetone mixture (-
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78 °C). After the temperature was constant, 2.5 mL of a 2.5 mol/L hexane solution of nbutyllithium was added dropwise to the reaction flask with a syringe. The progress of the
reaction was monitored by TLC. The TLC developing solvent was a mixed solution of
ethyl acetate and hexane 1:5. After all the reactants were converted into intermediate
products, 0.53 mL of dimethyl diselenide liquid was added dropwise to the reaction flask
with a syringe. The progress of the reaction was monitored by TLC. After the reaction was
completed, the reaction was quenched by the addition of 0.7 mL of saturated brine. The
reaction solution was diluted with ethyl acetate, and washed with water to remove THF
and other water-soluble impurities. The aqueous phase was extracted three times with ethyl
acetate, the aqueous phase was discarded and the organic phases were combined. The
organic phase was washed three times with saturated brine and the aqueous phase was
discarded. The organic phase is dried over anhydrous magnesium sulfate. After filtration
and rotary evaporation, a crude product was gained. Further purification using a silica gel
column yields a product of higher purity. The eluent of the silica gel column was a mixed
solution of ethyl acetate and hexane 1:6.5. Because dimethyl diselenide has a certain
pungent odor, it is oxidized by using a bleaching agent in contact with a dimethyl
diselenium reaction container. Selenium-containing waste liquid should be collected in a
specific container to avoid environmental pollution.
The yield of this step is about 60%.
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3.1.3

Detert-butyldimethylsilyl protection

3.1.3.1 Experimental procedure

Figure 3.4 The equation for detritylation reaction.
The reaction equation of deprotection of 3’,5’-diTBDMS-5-Se-dU (Compound 8)
is shown in Figure. 3.4. 490 mg of compound 8 was weighed into a 100 mL round bottom
flask. The flasks were dried over high vacuum for 30 min. The flasks were purged with
argon and an argon balloon was placed to maintain a constant pressure and ensure an argon
atmosphere during the reaction. Compound 8 was dissolved in 20 mL of anhydrous
tetrahydrofuran. A round bottom flask containing the compound 8 tetrahydrofuran solution
was placed in an ice water bath. After the temperature was stabilized, 3.56 mL of a 1 mol/L
tetrabutylammonium fluoride in tetrahydrofuran solution was added dropwise to a round
bottom flask containing the Compound 8 tetrahydrofuran solution. The flask was removed
from the ice water bath and stirred at room temperature for two hours. The progress of the
reaction was monitored by TLC. The TLC developer was a 5% methanol in
dichloromethane. After completion of the reaction, the reaction was quenched by the
addition of 0.7 mL of saturated brine. The reaction solution was diluted with ethyl acetate,
and washed with water to remove THF and other water-soluble impurities. The aqueous
phase was extracted three times with ethyl acetate, the aqueous phase was discarded and
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the organic phases were combined. The organic phase was washed three times with
saturated brine and the aqueous phase was discarded. The organic phase is dried over
anhydrous magnesium sulfate. Filtration and rotary evaporation gave a crude product.
Further purification using a silica gel column yields a product of higher purity. The eluent
of the silica gel column was 6% methanol in dichloromethane.
The yield of this step is about 90%.
3.1.4

Dimethoxytrityl (DMTr-) protection

3.1.4.1 Experimental procedure

Figure 3.5 Chemical reaction equation for dimethoxytrityl protecting reaction.

The reaction equation of the tritylation of 5-Se-Thymidine (Compound 9) is shown
in Figure. 3.5. 340 mg of compound 9 was mixed with 5 mg of 4-dimethylaminopyridine
(DMAP) in a 25 mL round bottom flask. 538.74 mg DMTr-Cl was placed in another 25
mL round bottom flask. The flasks were dried over high vacuum for 30 min. The flasks
were purged with argon and an argon balloon was placed to maintain a constant pressure
and to ensure an argon atmosphere during the reaction. The DMTr-Cl was dissolved in 6
mL of anhydrous pyridine, and a pyridine solution of DMTr-Cl was added dropwise to a
round bottom flask containing Compound 9 and DMAP using a syringe. The reaction was
stirred at room temperature for 2 h. The progress of the reaction was examined by TLC.
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The TLC developer was a 5% methanol in dichloromethane. After the reaction was
completed, the reaction was quenched by the addition of 0.7 mL of saturated brine. The
reaction solution was diluted with ethyl acetate and washed with water to remove DMF
and other water-soluble impurities. The aqueous phase was extracted three times with ethyl
acetate, the aqueous phase was discarded and the organic phases were combined. The
organic phase was washed three times with saturated brine and the aqueous phase was
discarded. The organic phase is dried over anhydrous magnesium sulfate. After filtration
and rotary evaporation, a crude product was gained. Further purification using a silica gel
column yields a product of higher purity. The eluent of the silica gel column was 1.5%
methanol in dichloromethane.
The yield of this step is about 80%.
3.1.4.2 Proposed mechanism

Figure 3.6 Schematic diagram of the mechanism of phosphoramidite synthesis
reaction.
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The reaction mechanism of this step is shown in Figure 3.6. First, DMAP replaces
the chlorine atom of DMTr-Cl to become a better leaving group, thereby activating carbon
atoms. Then, the hydroxyl group at the 3'-position of the sugar ring attacks the carbon atom
to undergo a substitution reaction. The role of DMAP in the reaction process is the catalyst
and proton acceptor.
3.2

Solid Phase Synthesis of the Selenium Nucleic Acid
Millions of oligonucleotides are synthesized and used in the laboratory every year

in the world. For most applications, only a tiny amount of DNA is needed. Moreover, the
synthesis of oligonucleotides is mainly carried out at a scale below 40 nmol. This is enough
for most biological and biochemical experiments. But for biophysical studies such as
nuclear magnetic resonance and X-ray diffraction crystallography, more DNA (more than
10 μmol) needs to be prepared. In extreme cases, it is often required to achieve quantities
of several kilograms for the preparation of drug molecules (e.g., antisense
oligonucleotides). Solid phase synthesis of oligonucleotides has emerged. And almost
exclusively fully automated solid phase synthesis can meet all of the above requirements73,
74

.
3.2.1

Advantages of solid phase synthesis

Solid phase synthesis is widely used in the synthesis of peptides, oligonucleotides,
oligosaccharides, and various combinatorial chemistries. Solid-phase chemical synthesis
was invented by Bruce Merrifield in the 1960s, and he won the 1984 Nobel Prize in
Chemistry.
The starting reagent of the solid phase synthesis method is immobilized on a solid
support in the reaction column and the filter, and other reaction reagents and solvents can
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freely pass through the reaction. Relative to solution synthesis, solid phase synthesis can
use a relatively large amount of solution phase reagent to promote the reaction to proceed
more quickly and thoroughly. Moreover, impurities and excess reagents are rinsed off so
no additional purification process is required after each step is completed. At the same time,
the solid phase synthesis process can also be fully automated through a computer.
3.2.2

Solid supports

The solid support is an insoluble particle and usually has a particle size of 50-200
μm. During the synthesis, oligonucleotides are attached to these particles. There are many
different particles to choose from, but microporous glass (CPG) and polystyrene have
proven to be the most suitable.
3.2.2.1 Controlled-pore glass (CPG)
Controlled-pore glass is chemically stable, does not absorb solvent swelling, and
has deep pores that allow for oligonucleotide synthesis reactions. A glass support with a
pore size of 500 Å is suitable for mechanical synthesis of short-chain oligonucleotides.
However, when a 500 Å pore size vector is used to synthesize an oligonucleotide sequence
of more than 40 bases in length, the yield of the synthesis decreases sharply. This is because
the growing oligonucleotide strand blocks the micropores and prevents the reaction reagent
from diffusing into the support. Although larger pore size matrices are more fragile, it is
more appropriate to use controlled-pore glass with a pore size of up to 1000 Å when
synthesizing oligonucleotide sequences of up to 100 bases in length. Moreover, for the
synthesis of longer oligonucleotide sequences, it is even possible to use a vector with a
pore size of 2000 Å.
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3.2.2.2 Polystyrene (PS)
Highly cross-linked polystyrene beads have good hydrophobicity and thus higher
oligonucleotide synthesis efficiency, especially at very low scales (eg 40 nmol). A solid
phase carrier for the synthesis of a conventional oligodeoxynucleotide is usually prepared
by attaching 20-30 μmol of nucleoside per gram of the carrier. The efficiency of synthesis
of higher loading oligonucleotides is significantly reduced. This is because the steric
hindrance effect of the oligonucleotide strands adjacent to each other on the carrier
increases as the load increases. However, polystyrene carriers with a loading of up to 350
μmol / g are used in some applications, especially the synthesis of short-chain
oligonucleotides. This also makes it possible to synthesize a large number of
oligonucleotide sequences.
3.2.3

The phosphoramidite method

A variety of solution phase oligonucleotide synthesis methods have been developed
over the years. From the early studies of the hydrogen phosphite and phosphotriester
methods by Michelson and Todd in the 1950s75, 76, and the attempt of Khorana to the
phosphodiester method77, the re-study of the phosphotriester method and the development
of the phosphite triester method in the 1960s and 1970s78-83, all these methods have their
own drawbacks. The phosphoramidite method pioneered by Marvin Caruthers in the early
1980s combined with automated solid phase synthesis became the current universal
choice82.
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3.3

High-Performance Liquid Chromatogram (HPLC) Analysis for Selenium
Modified DNA Sequences
3.3.1

Reverse phase HPLC procedure

The HPLC equipment used in our lab is a Hewlett Packard Series 1100 HPLC
System. The HPC column is Welch Materials, Inc. UltisilTM XB-C18 chromatographic
column. It’s a reverse phase column.
The mobile phase is a mixture of Buffer A and Buffer B. Buffer A is 20 mM
triethylamine in acetic acid(TEA-Ac) in deionized water solution. Buffer B is 20 mM TEAAc in water/acetonitrile (50%/50%) solution. The mobile phase composition gradient
varies for DMTr-on or DMTR-off DNA analysis because of the polarity difference.

Table 3.1 Mobile phase composition gradient for DMTr-on DNA sequences
purification.
Time
B%
0

5

8

60

12

100

20

100

Table 3.2 Mobile phase composition gradient for DMTr-off DNA sequences
purification.
Time
B%
0

5

15

40

17

100

66

20

100

The retention time for ideal DNA is about 12 min while that for short oligo usually
is 5 min. If we observe only one single peak at 12 min in the HPLC chromatogram, there
is no short oligo but right DNA.
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3.3.2

HPLC chromatogram for W3 (5 '-d(CCAAAGT5- SeTGC)-3')

Figure 3.7 HPLC chromatogram of DNA sequence W3 containing only one
selenium-modified thymidine.
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3.3.3

HPLC chromatogram for W4 (5'-d(GCAACTT5 -SeT GG)-3')

Figure 3.8 HPLC chromatogram of the DNA sequence W4 of all thymidinecontaining selenium-modified DNA.

3.3.4

Summary

The chromatograms are all single peaks, indicating that the DNAs after synthesis
and purification don’t contain too many short oligos. We can do an mass spectra to make
sure that our sample is pure enough for subsequent biochemical experiments. Besides, the
absorption peak at a wavelength of 300 nm is still strong, indicating that the DNA molecule
is indeed selenium modified.
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3.4

Mass Spectra of Nucleic Acid
MALDI(+)-TOF spectra of W1 (5'-d(CCAAAGTTGC)-3')
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Figure 3.9 MALDI-TOF(+) MS analysis of the DMTr-off DNA W1 (5’-d
(CCAAAGTTGC)-3’). Average mass [M] = 3012.034. Calculated [M + H]+: 3013.041.
Measured [M + H]+: 3006.158.
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MALDI(+)-TOF spectra of W2 (5'-d(GCAACTTTGG)-3')
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Figure 3.10 MALDI-TOF(+) MS analysis of the DMTr-off DNA W2 (5’-d
(GCAACTTTGG)-3’). Average mass [M] = 3043.046. Calculated [M + H]+: 3044.053.
Measured [M + H]+: 3039.333.
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3.4.3

MALDI(+)-TOF

spectra

of

5’-double

overhang

DNA
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Figure 3.11 MALDI-TOF(+) MS analysis of the DMTr-off 5’-double overhang
DNA (5’-d (CGGCAACTTTGG)-3’). Average mass [M] = 3630.429. Calculated [M + H]+:
3631.436. Measured [M + H]+: 3628.923.
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3.4.4
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Figure 3.12 MALDI-TOF(+) MS analysis of the DMTr-off 5’-double overhang
DNA (CGGCAACTTTGG). Average mass [M] = 3661.429. Calculated [M + H]+:
3662.429. Measured [M + H]+: 3660.152.
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3.4.5

MALDI(+)-TOF spectra of single selenium modified 5’-double overhang
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Figure 3.13 MALDI-TOF(+) MS analysis of the DMTr-off single selenium modified
5’-double overhang DNA (CGGCAACTT(5-SeT)GG). Average mass [M] = 3740.400.
Calculated [M + H]+: 3741.400. Measured [M + H]+: 3739.581.
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3.4.6

MALDI(+)-TOF spectra of double selenium modified 5’-double overhang

Intens. [a.u.]
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Figure 3.14 MALDI-TOF(+) MS analysis of the DMTr-off double selenium
modified 5’-double overhang DNA (CGGCAACT(5-SeT)(5-SeT)GG). Average mass [M] =
3819.371. Calculated [M + H]+: 3820.371. Measured [M + H]+: 3818.136.
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3.4.7

MALDI(+)-TOF spectra of triple selenium modified 5’-double overhang

Intens. [a.u.]
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Figure 3.15 MALDI-TOF(+) MS analysis of the DMTr-off triple selenium modified
5’-double overhang DNA (CGGCAAC(5-SeT)(5-SeT)(5-SeT)GG). Average mass [M] =
3898.342. Calculated [M + H]+: 3899.342. Measured [M + H]+: 3896.818.

3.4.8

Summary

The measured molecular ion peak is almost the same as the theoretical value
obtained by calculation. According to the HPLC chromatogram and the MS spectra of the
DNA, we can believe that the synthesized DNA molecules are correct, and the selenium
modification is successful. Because the molecular ion peaks are pretty clear, our samples
are pure enough to do the crystal study.
3.5

Melting Study for Selenium Nucleic Acid
Complementary DNA mixtures typically have two different conformations, a

double-stranded structure, and a single-stranded structure. It is not difficult to speculate
from the thermodynamic law that the DNA molecules are mainly in the form of doublestrand in the case of lower temperature, and the DNA molecules are mostly in a single-
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stranded way at a higher temperature and lower concentration. The process of breaking
double-stranded DNA into single strands is known as DNA denaturation, or DNA
denaturing. The melting temperature of DNA refers to the temperature at which 50% of
DNA in a sample has denatured from double-stranded DNA to single-stranded DNA. The
amount of strand separation, or melting, is measured by the absorbance of the DNA
solution at 260nm. Nucleic acids absorb light at this wavelength because of the electronic
structure in their bases, but when two strands of DNA come together, the close proximity
of the bases in the two strands quenches some of this absorbance. When the two strands
separate, this quenching disappears, and the absorbance rises 30%-40%. This is called
Hyperchromicity. The Hypochromic effect is the effect of stacked bases in a double helix
absorbing less ultra-violet light.85, 86
3.5.1

Melting study for DNA double-strand

A mixed buffer solution of pH=7.4, 50 mmol/L Tris-HCl, 100 mmol/L NaCl, and
1 mmol/L EDTA was prepared. The four DNA sequences used in the experiments were all
configured to 1 mmol/L. Add 988 μL of buffer solution to each of the four quartz cuvettes
labeled 1, 2, 3, and 4, and add 6 μL of W1 to the 1 and 2 cuvettes respectively, 6 μL of W2
to the 1 and 3 cuvettes, 6 μL of W3 to the 3 and 4 cuvettes, and 6 μL of W4 to the 2 and 4
cuvettes. The concentration of DNA double strands in the four cuvettes was 6 μmol/L.
Place the four cuvettes in the UV-Vis absorption tester in sequence. Slowly warm up to
90ºC to melt, then cool down to 15ºC to ensure that the DNA is fully integrated into a
double-stranded structure. Set the measured absorption wavelength to 260 nm, the
measurement speed to 0.5ºC/min, the onset temperature to 25ºC, and the termination
temperature to 95ºC.
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Figure 3.16 Normalized thermal-denaturation curves of four DNA double-stranded
molecules containing different numbers of selenium modifications.

We can obtain not only the trending lines in Figure 3.16 by analyzing the melting
study data but also the thermodynamic data, such as Tm and ΔTm. Tm is the temperature
where the fraction ssDNA rate of change over temperature is the biggest. We regard the
native DNA, W1-W2, as the standard. The Tm difference between the selenium modified
DNA and native DNA is ΔTm.

Table 3.3 The Tm and ΔTm data of the four DNA double-strands via melting study
Sequence ID
Tm/ºC
ΔTm/ºC
W1-W2

44.8

0
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W1-W4

41.9

-2.9±0.1

W2-W3

43.7

-1.1±0.1

W3-W4

40.8

-4.0±0.2

The Tm of the DNA double-strand decreases as the number of selenium-containing
modified bases increases. However, the Tm difference isn’t very notable. The selenium
modification affects the thermal stability of DNA double-strand but not too much.
3.5.2

Melting study for DNA and DB2429 complex

A mixed buffer solution of pH=7.4, 50 mmol/L Tris-HCl, 100 mmol/L NaCl, and
1 mmol/L EDTA was prepared. The four DNA sequences used in the experiments were all
configured to 1 mmol/L. Add 976 μL of buffer solution and 12 μL of 0.5 mmol/L DB2429
solution to each of the four quartz cuvettes labeled 1, 2, 3, and 4, respectively, and add 6
μL of W1 to the 1 and 2 cuvettes, 6 μL of W2 to the 1 and 3 cuvettes, 6 μL of W3 to the 3
and 4 cuvettes, and 6 μL of W4 to the 2 and 4 cuvettes. The concentration of DNA doublestrands binding with small molecule in the four cuvettes was 6 μmol/L. Place the four
cuvettes in the UV-Vis absorption tester in sequence. Slowly warm up to 90ºC to melt, then
cool down to 15ºC to ensure that the DNA is fully integrated into a double-stranded
structure. Set the measured absorption wavelength to 260 nm, the measurement speed to
0.5ºC /min, the onset temperature to 25ºC, and the termination temperature to 95ºC.
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Figure 3.17 Normalized thermal-denaturation curves of four DNA double-stranded
molecules containing different numbers of selenium modifications and small molecule
DB2429 complexes.
The method we calculate Tm and ΔTm of DNA binding with DB2429 is all the
same as what we did for DNA double-strand only.
Table 3.4 The Tm and ΔTm data of the four DNA double-strands binding with
DB2429 via melting study
Sequence ID
Tm/ºC
ΔTm /ºC
W1-W2-DB2429

56.7

0

W1-W4-DB2429

56.8

0.1±0.1

W2-W3-DB2429

55.9

-0.8±0.1

W3-W4-DB2429

55.8

-0.9±0.1
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The Tm of the DNA double-stranded and small-molecule DB2429 complex are
almost all the same. The thermal stability of the DNA double-stranded isn’t affect by
selenium modification. The ΔTm of the double-stranded DNA binding with the small
molecule is smaller than DNA alone. It can be inferred that DB2429 binding tightly at the
DNA minor groove.
3.5.3

Melting study for DNA and DB2457 complex

A mixed buffer solution of pH=7.4, 50 mmol/L Tris-HCl, 100 mmol/L NaCl, and
1 mmol/L EDTA was prepared. The four DNA sequences used in the experiments were all
configured to 1 mmol/L. Add 976 μL of buffer solution and 12 μL of 0.5 mmol/L DB2457
solution to each of the four quartz cuvettes labeled 1, 2, 3, and 4, respectively, and add 6
μL of W1 to the 1 and 2 cuvettes, 6 μL of W2 to the 1 and 3 cuvettes, 6 μL of W3 to the 3
and 4 cuvettes, and 6 μL of W4 to the 2 and 4 cuvettes. The concentration of DNA doublestrands binding with small molecule in the four cuvettes was 6 μmol/L. Place the four
cuvettes in the UV-Vis absorption tester in sequence. Slowly warm up to 90ºC to melt, then
cool down to 15ºC to ensure that the DNA is fully integrated into a double-stranded
structure. Set the measured absorption wavelength to 260 nm, the measurement speed to
0.5ºC /min, the onset temperature to 25ºC, and the termination temperature to 95ºC.
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Figure 3.18 Normalized thermal-denaturation curves of four DNA double-stranded
molecules with different numbers of selenium modifications and small molecule DB2457
complexes.
The calculation of Tm and ΔTm of DNA binding with DB2457 is all the same as
DNA binding with DB2429.
Table 3.5 The Tm and ΔTm data of the four DNA double-strands binding with
DB2457 via melting study
Sequence ID
Tm/ºC
ΔTm /ºC
W1-W2-DB2457

59.8

0

W1-W4-DB2457

59.4

-0.4±0.1

W2-W3-DB2457

59.9

0.1±0.1

W3-W4-DB2457

59.3

-0.5±0.1
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Similar to DB2429, the Tm of the DNA double-stranded and small-molecule
DB2457 complex are also almost the same. The selenium modification doesn’t
significantly change the melting temperature or alter the duplex structure. The ΔTm of the
double-stranded DNA binding with the small molecule is smaller than DNA alone. It can
be inferred that DB2457 binding tightly at the DNA minor groove.
At the temperature range from 40 to 50ºC, there is a shoulder in the trending line.
That might be the effect caused by the small molecule DB2457 released from the DNA
double-strand which means that DB2457 binding with DNA is not as tight as DB2429.
3.6

Crystallization and Structure Studies
For crystal screening, 24 different buffers of Hampton Scientific's Nucleic Acid

Mini Screen Kit reagent were used. The DNA double-strand concentration was 0.2 mmol/L
in deionized water, and the small molecule concentration was 0.3 mmol/L in deionized
water. 500 mL of 15% v/v MPD aqueous solution or 20% v/v MPD aqueous solution was
first added to the crystallization vial during crystal screening. Then 0.5 μL of the DNA
sample solution and 0.5 μL of the crystallization reagent were evenly mixed on the slide
and inverted on the crystallizing cell. Crystal growth was observed every other day.
3.6.1

Crystallization

result

for

5’-d(CCAAAGTTGC)-3’

and

5’-

d(GCAACTTTGG)-3’ double strand DNA sequence binding with a small
molecule.
As we talked at the very beginning, we synthesized 4 different DNA sequences,
which are listed in the form below. W1 and W2 can form a native DNA double strand. W1
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with W4 or W2 with W3 can form a DNA double strand with single selenium modified.
W3 and W4 can form a double selenium modified DNA double strand.
Table 3.6 DNA sequences we synthesized which can bind with the small molecule
DB2429 and DB2457.
DNA Sequences
Sequence Name
5’-d(CCAAAGTTGC)-3’

W1

5’-d(GCAACTTTGG)-3’

W2

5’-d(CCAAAGT5-SeTGC)-3’

W3

5’-d(GCAACTT5-SeTGG)-3’

W4

We used the synthesized DNA sequences alone or binding with small molecule
trying to create some crystal to do the X-ray diffraction. The figures in the following are
some of the crystals we obtained.
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W3-W4 Scale: 2

W1-W4-DB2429 Scale: 1

W2-W3-DB2429 Scale: 2

W3-W4-DB2429 Scale: 2

W1-W2-DB2457 Scale: 2

W2-W3-DB2457 Scale: 1

Figure 3.19 Experimental DNA crystals obtained.

The crystal quality is scaled by its shape and size. The higher scores the crystal get,
the more possibility to get useful diffraction data. Perfect crystal shall get 5 scores while
poor crystal can only get 1.
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From the crystal figure, the crystal is small and numerous, and the shape is irregular.
We sent the crystals to do X-ray diffraction. Unfortunately, we didn't get useful X-ray
diffraction data with those DNA sequences. Subsequent work will continue to optimize
crystallization conditions for better crystals.
3.6.2

Crystallization study for DNA sequences with 3’-position overhangs

Since we cannot get good crystals, we tried to add a GC overhang at 3’-position for
each DNA sequence. As the overhangs introduced, the DNA double-strand shall form a
GC sticky end. The sticky end could connect two DNA double strands easily which may
make it easier to form better crystals. The form below shows the DNA sequences we
synthesized.
Table 3.7 DNA sequences we synthesized which has a GC overhang at 3'-position.
DNA Sequences
Sequence Name
5’-d(CCAAAGTTGCGC)-3’

Top

5’-d(GCAACTTTGGGC)-3’

N

5’-d(GCAAC5-Se TTTGGGC)-3’

S

5’-d(GCAAC5-Se T5-Se TTGGGC)-3’

D

5’-d(GCAAC5-Se T5-Se T5-SeTGGGC)-3’

T

The Top sequence can form a double strand DNA with S, D or T. The newly formed
DNA double-strand should contain single, double or triple selenium modified.
Table 3.8 The DNA double brand could be formed by the synthesized DNA
sequences. To be read vividly, the bottom sequence is presented in 3' to 5' direction and
the GC overhangs are highlighted.
Name
DNA Double Brand Sequences
N

5’-d(

CCAAAGTTGCGC)-3’
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3‘-d(CGGGTTTCAACG
S

5-d(

CCAA

)-5’

AGTTGCGC)-3’

3‘-d(CGGGTT(5-SeT)CAACG )-5’
D

5’-d(

CCA

A

AGTTGCGC)-3’

3‘-d(CGGGT(5-SeT)(5-SeT)CAACG
T

5’-d(

CC

A

A

)-5’

AGTTGCGC)-3’

3‘-d(CGGG(5-SeT)(5-SeT)(5-SeT)CAACG )-5’

However, we couldn’t get any good shape crystals by using these DNA sequences.
Still, we did a screening test. The screening result is shown in the form below.
Table 3.9 Screening result for the DNA double strands with 3'-overhangs.

Although we didn’t have good crystal which can do the X-ray diffraction to finish
the structure study, we can still come to the conclusion that DNAs with selenium modified
could be easier to form crystals. As we can see in the table above, the more selenium atoms
in the DNA double strand, the faster and the more crystal we observed.
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3.6.3

Crystallization study for DNA sequences with 5’-position overhangs

We cannot get better crystal with 3’-position GC overhangs. So, we had another
trial with 5’-position overhangs. The sequences we synthesized were listed below.
Table 3.10 DNA sequences we synthesized which has a GC overhang at 5'-position.
DNA Sequences
Sequence Name
5’-d(CGCCAAAGTTGC)-3’

Top

5’-d(CGGCAACTTTGG)-3’

N

5’-d(CGGCAAC TT5-Se TGG)-3’

S

5’-d(CGGCAAC T5-Se T5-Se TGG)-3’

D

5’-d(CGGCAAC5-Se T5-Se T5-SeTGG)-3’

T

The Top sequence can form a double strand DNA with S, D or T. The newly formed
DNA double-strand should contain single, double, or triple selenium modified.
Table 3.11 The DNA double brand could be formed by the synthesized DNA
sequences. To be read vividly, the bottom sequence is presented in 3' to 5' direction and
the GC overhangs are highlighted.
Name
DNA Double Brand Sequences
N

5’-d(CGCCAAAGTTGC)-3’
3‘-d(

S

5-d(CGCC
3‘-d(

D

A

AAGTTGC)-3’

GG(5-SeT)(5-SeT)TCAACGGC)-5’

5’-d(CGCC
3‘-d(

AAAGTTGC)-3’

GG (5-SeT)TTCAACGGC)-5’

5’-d(CGCC
3‘-d(

T

GGTTTCAACGGC)-5’

A

A

AGTTGC)-3’

GG(5-SeT)(5-SeT)(5-SeT)CAACGGC)-5’
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Figure 3.20 Some good crystals we got by using 5'-position GC overhangs.

We are happy to see that we got some good crystals when we introduced GC
overhangs at 5’-position. We mounted the crystals and tried to do the X-ray diffraction
experiment. However, we still didn’t get good data even if we use the crystals which have
regular shapes.
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3.6.4

The effect on the crystallization of different MPD concentration.

Table 3.12 The crystallization result for the single selenium modified DNA doublestrand with 5'-position GC overhangs. The MPD concentration is distributed from 20% to
45%. The pictures are what the crystals looked like on the third day.

Table 3.13 The crystallization result for the single selenium modified DNA doublestrand with 5'-position GC overhangs binding with small molecule DB2429. The MPD
concentration is distributed from 20% to 45%. The pictures are what the crystals looked
like on the third day.

Table 3.14 The crystallization result for the single selenium modified DNA doublestrand with 5'-position GC overhangs binding with small molecule DB2457. The MPD
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concentration is distributed from 20% to 45%. The pictures are what the crystals looked
like on the third day.

Table 3.15 The crystallization result for the double selenium modified DNA doublestrand with 5'-position GC overhangs. The MPD concentration is distributed from 20% to
45%. The pictures are what the crystals looked like on the third day.

Table 3.16 The crystallization result for the double selenium modified DNA doublestrand with 5'-position GC overhangs binding with small molecule DB2429. The MPD
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concentration is distributed from 20% to 45%. The pictures are what the crystals looked
like on the third day.

Table 3.17 The crystallization result for the double selenium modified DNA doublestrand with 5'-position GC overhangs binding with small molecule DB2457. The MPD
concentration is distributed from 20% to 45%. The pictures are what the crystals looked
like on the third day.
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Table 3.18 The crystallization result for the triple selenium modified DNA doublestrand with 5'-position GC overhangs. The MPD concentration is distributed from 20% to
45%. The pictures are what the crystals looked like on the third day.

Table 3.19 The crystallization result for the triple selenium modified DNA doublestrand with 5'-position GC overhangs binding with small molecule DB2429. The MPD
concentration is distributed from 20% to 45%. The pictures are what the crystals looked
like on the third day.

Table 3.20 The crystallization result for the triple selenium modified DNA doublestrand with 5'-position GC overhangs binding with small molecule DB2457. The MPD
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concentration is distributed from 20% to 45%. The pictures are what the crystals looked
like on the third day.

Through the screening result above, we can conclude that higher MPD
concentration can form crystals easier and better. And the sequences with more Semodification can create crystal more easily.

3.6.5

Summary

Single overhang and double overhangs DNA can form better crystals than triple
overhangs DNA. The 5’-overhang DNA can form better crystals than 3’-overhang DNA.
Single overhang and double overhangs DNA can form better crystals than triple overhangs
DNA. The 5’-overhang DNA can form better crystals than 3’-overhang DNA. Higher MPD
concentration can form more crystals. The sequences with more Se-modification can form
crystal more easily.
After acquiring the DNA crystal, the structure can be determined by X-ray
diffraction. The crystal structure of each DNA molecule can be obtained by analyzing the
X-ray diffraction data.
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However, although we sent the DNA crystals to do the X-ray diffraction, we didn’t
get any useful diffraction data.
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4

CONCLUSIONS

The two major challenges in nucleic acid X-ray crystallography, crystallization and
phasing determination, can be partially solved by introducing selenium modification into
DNA. 5-Se-thymidine was successfully synthesized and incorporated into DNA
oligonucleotides via solid-phase synthesis to facilitate the crystallization and phasing.
Small molecule DB2429 and DB2457 were co-crystalized with Se-DNAs and nice
crystals were obtained, which are better than the native crystals. 5’-d(CCAAAGTTGC)-3’
and 5’-d(GCAACTTTGG)-3’ duplex can crystallize but doesn’t have useful X-ray
diffraction data even that it’s selenium modified. The complex of DNA duplex binding
with small molecule doesn’t have good diffraction data, as well.
The melting study reveals that the selenium modification has no signification
perturbation to the DNA stability.
Since we couldn’t get good structure data from the regular DNA double-strands
(native and Se-modified) after the X-ray diffraction, we tried to introduce overhangs to the
duplex through which we could get a sticky end. The 5’-overhang DNA can form better
crystals than 3’-overhang DNA. Single overhang and double overhangs DNA can form
better crystals than triple overhangs DNA. We also find out that higher MPD concentration
can form more crystals quickly and 35% MPD aqueous solution shall be the best reservoir
solution for crystallization. The sequences with more Se-modification can create crystal
more efficiently which means that selenium atom in the DNA molecule affects
crystallization.

98

After obtaining the DNA crystal, the structure can be determined by X-ray
diffraction. The crystal structure of each DNA molecule can be obtained by analyzing the
X-ray diffraction data.
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APPENDICES
Appendix A Nucleic Acid Mini Screen (NAM)
The Nucleic Acid Mini Screen™ is an efficient screen formulated to assist in the
determination of preliminary crystallization conditions of nucleic acid fragments.
Using 1 to 4 mM oligonucleotide stock concentration the screen requires less than
25 microliters of sample.
The screen evaluates sample concentration, temperature, pH, monovalent cations,
divalent cations, and polyamines. To complete the screen, one will need 1) HR2-118
Nucleic Acid Mini Screen, a set of twenty-four, 1 milliliter volumes of reagent and 2) 35%
v/v (+/-)-2-Methyl-2,4-pentanediol, the dehydrant for the reagent well / reservoir (available
separately as HR2-863 35% v/v (+/-)-2-Methyl-2,4-pentanediol).
The composition of the nucleic acid mini screen allows one to apply the formulation
to other nucleic acids such as deoxy- and ribozymes, pseudoknots and tRNAs.
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Figure A.0.1 Nucleic acids mini screen kit conditions.
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Appendix B The Synthesis of the Nucleotide with an Extended Pyrimidine Ring
Appendix B.1 Introduction
By using uridine as the starting reactants, the 3‘,5’-TIPDS-biscyc-selenoate (TiOS)
was synthesized via 4 steps. The 4 steps are TIPDS protection, adding Ms-leaving group,
Boc-protection and selenium introduction. The newly synthesized biscyc-selenoate can be
used to synthesis novel nucleotide with seven or more-member ring as the base group. This
could be a very interesting research. There are many different small molecules we can use
to extend the base group ring. For now, we introduced ethylene glycol to extend the ring.
In the future, we may use many other interesting small molecules such as acetonitrile to
get aromatic extended ring. We can even synthesis sequences containing the new
nucleotide to figure out the interaction between conventional nucleotides.

Figure B.2 Synthesis route of 5-MeSe-T-phosphorimidite from 5-I-dU.

The synthesis route of biscyc-selenoate was shown in figure one. As we can see,
there are 4 steps totally to synthesis the selenoate from uridine. Firstly, we use TIPDS
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group to protect the 3’- and 5’-position hydroxy groups. Secondly, we use Ms-group as the
leaving group at 2’-position. Then, Boc-group is added to protect the nitrogen atom in the
pyrimidine ring. Finally, we introduce selenium into the molecule.
Appendix B.2 TIPDS Protection
Appendix B.2.1 Experimental procedure

Figure B.3 TIPDS protection reaction.

10 g uridine was dissolved in 250 mL pyridine (concentration is about 0.1 M). The
solution was cooled with ice bath. 15 mL TIPDS-Cl was added dropwise. The reaction was
stirred at room temperature overnight. The reaction process was detected by TLC (TLC
condition methanol: methylene chloride=1:20). When there was no uridine spot in the TLC
plate, pyridine was evaporated under reduced pressure. The residue was dissolved in DCM
and washed with 3M HCl. Then washed with sat. NaHCO3 and brine. The solution was
dried by MgSO4. Then concentrated by evaporator after filtration. Finally, purified by
column (with the eluent of methanol: methylene chloride=1:100).
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Appendix B.2.2 Proposed mechanism

Figure B.4 The proposed mechanism of TIPDS protection reaction.
The first step is an SN2 reaction. First, the oxygen atom in the 5’-hydroxy group
attacks the silica atom in the TIPDS-Cl and the chloride atom will be substituted, therefore.
The pyridine here will work as a base, which will take the proton released from the hydroxy
group. Then, 3’-hydroxy will react with the other silica though the same mechanism and
the ring shall be closed.
Appendix B.3 Adding Ms-Leaving Group
Appendix B.3.1 Experimental procedure

Figure B.5 Ms-leaving group adding reaction.
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6 g starting material 3’,5’-TIPDS-uridine was dissolved in 80 mL THF and
cooled down to 0℃. 5.1 mL TEA was added into the solution. Then treated with 1.4 mL
MsCl. Reaction will be finished in about 1 h. The reaction process was detected by TLC
(TLC condition methanol: methylene chloride=1:50). When there was no starting material
spot in the TLC plate, saturated NaCl solution was added to quench the reaction. The
residue was dissolved in DCM and washed with water and brine. The aqueous layer was
extracted by DCM. The organic layer was dried by MgSO4. Then concentrated by
evaporator after filtration. Finally, purified by silica gel column (with the eluent of
methanol: methylene chloride=1:100).
Appendix B.3.2 Proposed mechanism

Figure B.6 The proposed mechanism of Ms-leaving group adding reaction.

As shown in Figure B.6, the mechanism of Ms-leaving group adding reation is
addition-elimination. First, the hydrogen atom in the 2’-hydroxy group attacks the sulfur
atom in the Ms-Cl and a hydroxide will be formed during the process. Next, the electron
pair in the hydroxide reforms a double bond which eliminated the chloride.
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Appendix B.4 Boc-Protection
Appendix B.4.1 Experimental procedure

Figure B.7 Boc-protection reaction.
6.7 g starting material 2’-Ms-3’,5’-TIPDS-uridine and 1.4 g DMAP was dissolved
in 60 mL THF. 3.3 mL TEA was injected into the flask. 4.1 mL (Boc)2O was injected. The
reaction was stirred at room temperature for about 1 h. The reaction process was detected
by TLC (TLC condition Methanol: Methylene Chloride=1:100). When there was no
starting material spot in the TLC plate, the solvent was evaporated and redissolved in DCM.
The residue was dissolved in DCM and washed with water and brine. The aqueous layer
was extracted by DCM. The organic layer was dried by MgSO4. Then concentrated by
evaporator after filtration. Finally, purified by silica gel (with the eluent of ethyl acetate:
hexanes=1:7).

112

Appendix B.4.2 Proposed mechanism

Figure B.8 The mechanism of the Boc-protection reaction.

The mechanism of the Boc-protection reaction is shown in Figure B.8. As we can
see, the DMAP here works as a catalyst. First, DMAP actives the (Boc)2O through an
addition-elimination reaction. The actived Boc-group will react with the nitrogen through
the reaction.
Appendix B.5 Selenium Introduction
Appendix B.5.1 Experimental procedure

Figure B.9 Selenium introduction reaction.
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The reaction was conducted under Ar protection. 0.3 mL Me2Se2 and 3 mL THF
was injected into the round bottom flask. The flask was cooled down to -78℃ by dry using
ice and acetone mixture. 0.7 mL n-BuLi was injected under -78℃, then the solution was
warmed to room temperature. Keep stirring at r.t. for 15 min. 0.56 g starting material 1-NBoc-2’-Ms-3’,5’-TIPDS-uridine was dissolved in 3 mL THF and injected into the selenium
solution. The mixture was stirred at r.t. for 15-30 min. The reaction process was detected
by TLC (TLC condition Methanol: Methylene Chloride=1:50). When there was no starting
material spot in the TLC plate, the reaction was quenched with brine. The residue was
dissolved in DCM and washed with water and brine. The aqueous layer was extracted by
DCM. The organic layer was dried by MgSO4. Then concentrated by evaporator after
filtration. Finally, purified by silica gel column (with the eluent of ethyl acetate:
hexanes=1:7).
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Appendix B.5.2 Proposed mechanism

Figure B.10 The proposed mechanism of the selenium introduction reaction.

The reaction goes on by two steps. First, the dimethyl diselenide is cleaved by nbutyl lithium. Methyl selenide could be formed through the reaction. Next, the methyl
selenide attacks the carbonyl carbon at 6’-position. Through the electron transfer, the C-N
bond is open and the 2’-oxygen gets a negative charge. The oxygen becomes a strong
nucleophile, and the MsO-group is a very good leaving group. With an SN2 reaction, the
bicyclic intermediate is created. Then the methyl selenide replace the boc-group. After we
quench the reaction, the intermediate is hydrolyzed into the product.
Appendix B.6 Ring Formation Reactions
The methyl selenide group is a good leaving group, which make the carbonyl
carbon in the selenide ester very electrophilic. In the meantime, the nitrogen atom in imide
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group is supposed to be a nucleophile. If we have a small molecule which has both
electrophilic and nucleophilic group. The nucleophilic group could react with selenide ester
part while the electrophilic group with imide nitrogen. Though such reaction, we could
achieve the ring formation reaction.
Theoretically, all of the small molecule which contains both a good leaving group
and a nucleophilic part should be applicable to the ring formation reaction. Acetonitrile is
a very proper example.
First, the pKa of acetonitrile is only 25, which means that in base condition, the
methyl group might lose a proton and form a carbon cation. The carbon cation is pretty
stable because of the resonance effect, which is shown in the picture below. Carbon cation
can react with the selenide ester and replace the methyl selenide group as the role of a
nucleophile.

Figure B.11 The resonance structure for acetonitrile carbon anion. The carbon
anion should be relatively stable because of the resonance effect.

Second, as we know, though the resonance structure of the acetonitrile shown
below, it’s conspicuous that the carbon in the carbon-nitrogen triple bond shall contain
some positive charge. Then that carbon could be possible to react with the imide nitrogen
in the TiOS molecule as an electrophile.

Figure B.12 The resonance structure for acetonitrile. The cyan carbon contains
partial positive charge, which makes it electrophilic.

116

Now we have the eligible small molecule, acetonitrile, which might finish the ring
formation reaction. The probable reaction equation is shown as following.

Figure B.13 Reaction equation of the ring formation reaction for the TiOS with
acetonitrile.

If the reaction goes on well and just reacts as what we assumed, we should get the
ring expanded product finally. The reaction could be divided by two steps. First, in basic
condition, the methyl group attacks the carbonyl carbon. Through addition-elimination
reaction, the methyl selenide group is substituted. Second, the imide nitrogen attacks the
cyan carbon, and the new expanded ring is formatted.
The new product we shall get via TiOS react with acetonitrile isn’t perfect. The
CH2 in the expanded ring blocked the conjugated electrons, which makes the ring not
aromatic. It can be a solution if we transfer the methyl group into amino group or hydroxyl
group. By doing so, the long pair elections in N or O can be conjugated with the other
electrons in the ring. And the ring could be aromatic.
Some of the examples are listed as reaction equations below.
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Figure B.14 Reaction equation of the ring formation reaction for the TiOS with
cyanamide. The electrons in the p orbitals could be conjugated to make the expanded ring
aromatic.

Figure B.15 Reaction equation of the ring formation reaction for the TiOS with
cyanic acid. The electrons in the p orbitals could be conjugated to make the expanded ring
aromatic.

Figure B.16 Reaction equation of the ring formation reaction for the TiOS with
cyanic acid. The electrons in the p orbitals might not be conjugated to make the expanded
ring aromatic.

The small molecules listed above are just some of the possible reagents to expand
the ring. There are still a lot of alternative molecules for us to format the ring. As we talked
a lot before, any molecule that has or could have both leaving group and nucleophilic part
might be a good choice.
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Appendix B.7 Ethylene glycol introduction reaction
We tried with acetonitrile to format the ring before. However, there is no reaction
even if we heat it up overnight. It’s a brand-new molecule we got and we don’t know very
much of the properties. There is one thing we are certain is that the selenide ester can react
with alcohol.
So, we decided to use ethylene glycol to format the ring. The overall reaction is
shown as following.

Figure B.17 The overall reaction equations of the ring formation reaction for the
TiOS with ethylene glycol. We shall get a novel nucleoside with nine-member-ring.

The reaction contains 3 steps totally. First, the ethylene glycol reacts with selenide
ester part. The methyl selenide group is substituted. In Compound 5, both hydroxy group
and imide nitrogen are nucleophiles. We can protect the hydroxy group with mesyl group
to make it a good leaving. Then, it should be possible to finish the ring formation reaction.
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Appendix B.7.1 Experimental procedure

Figure B.18 Ethylene glycol introduction reaction.

0.4 g starting material Ti-OS was dissolved in 3 mL THF and 3 mL ethylene glycol.
0.4 mL TEA was added into the solution. Keep stirring at 65℃ overnight. The reaction
process was detected by TLC (TLC condition methanol: methylene chloride=1:4). When
there was no Ti-OS spot in the TLC plate, the residue was dissolved in DCM and washed
with water and brine. The aqueous layer was extracted by DCM. The organic layer was
dried by MgSO4. Then concentrated by evaporator after filtration. Finally, purified by silica
gel column (with the eluent of ethyl acetate: hexanes=1:1).
Appendix B.7.2 Proposed mechanism

Figure B.19 The mechanism of the ethylene glycol introduction reaction.

The ethylene glycol introduction reaction is also an addition elimination reaction.
The oxygen atom in the hydroxy group in ethylene glycol attacks the carbonyl carbon near
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the selenium. Then, the electron pair on the hydroxide reform a carbonyl bond and the
methyl selenide group is substituted.
Appendix B.8 Ms-leaving group introduction reaction
Appendix B.8.1 Experimental procedure

Figure B.20 Ms-leaving group introduction reaction.

0.1 g starting material Ti-OS-EGol was dissolved in 2 mL THF. 0.1 mL TEA was
added into the solution. 0.02 mL MsCl was injected. The reaction was stirred at room
temperature for about 1 h. The reaction process was detected by TLC (TLC condition
methanol: methanol: methylene chloride=1:4). When there was no Ti-OS-EGol spot in the
TLC plate, the residue was dissolved in DCM and washed with water and brine. The
aqueous layer was extracted by DCM. The organic layer was dried by MgSO4. Then
concentrated by evaporator after filtration. Finally, purified by silica gel column (with the
eluent of ethyl acetate: hexanes=1:2).
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Appendix B.9 The synthesis for the nucleotide with an extended pyrimidine ring

Figure B.21The final step for the synthesis is a ring formation reaction. We have
both nucleophile and electrophile in the molecule. And they are not too far away from each
other. Theoretically, we can do the reaction finally.

Now, we have already got 150 mg Ms-protected Ti-OS-EGol. There is only one
step left to our final product. It’s a ring formation step, as the picture showing above. If
everything is going on well, we shall get the novel eight-member ring nucleotide finally.
It is possible to extend pyrimidine ring via TiOS intermediate. In fact, all of the
small molecules which contain both a good leaving group and a nucleophilic part should
be applicable to the ring formation reaction. Acetonitrile and a series of acetonitrile
derivatives are suitable for the ring formation. However, despite we tried different basic
condition, different solvent, and different temperature, there is still no reaction.
To make the reaction easier, we tried ethylene glycol. After reacting overnight at
65℃, we observed the first step reaction finally. Although we still haven’t done the ring
formation reaction, we believe that we can make it finally and we will keep working on it.

